176 related articles for article (PubMed ID: 16850369)
21. The immunosuppressive pipeline: meeting unmet needs in liver transplantation.
Selzner N; Grant DR; Shalev I; Levy GA
Liver Transpl; 2010 Dec; 16(12):1359-72. PubMed ID: 21117245
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients.
Vincenti F; de Andrés A; Becker T; Choukroun G; Cole E; González-Posada JM; Kumar MA; Moore R; Nadalin S; Nashan B; Rostaing L; Saito K; Yoshimura N
Transpl Int; 2006 Jun; 19(6):446-57. PubMed ID: 16771865
[TBL] [Abstract][Full Text] [Related]
23. Current and evolving immunosuppressive regimens in kidney transplantation.
Gaston RS
Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S3-21. PubMed ID: 16567239
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppression.
Derek E; Dhanireddy K
Curr Opin Organ Transplant; 2012 Dec; 17(6):616-8. PubMed ID: 23095440
[No Abstract] [Full Text] [Related]
25. Status of liver and gastrointestinal transplantation at the University of Miami.
Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
[TBL] [Abstract][Full Text] [Related]
26. Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation.
Dandel M; Lehmkuhl HB; Knosalla C; Hetzer R
Transpl Immunol; 2010 Jul; 23(3):93-103. PubMed ID: 20434559
[TBL] [Abstract][Full Text] [Related]
27. Operational tolerance: past lessons and future prospects.
Levitsky J
Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppression in the era of biological agents.
Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J
Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103
[TBL] [Abstract][Full Text] [Related]
29. Current trends in immunosuppression for lung transplantation.
Floreth T; Bhorade SM
Semin Respir Crit Care Med; 2010 Apr; 31(2):172-8. PubMed ID: 20354930
[TBL] [Abstract][Full Text] [Related]
30. New directions for induction immunosuppression strategy in solid organ transplantation.
Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
[TBL] [Abstract][Full Text] [Related]
31. Kidney transplantation: the ideal immunosuppression regimen.
Yabu JM; Vincenti F
Adv Chronic Kidney Dis; 2009 Jul; 16(4):226-33. PubMed ID: 19576552
[TBL] [Abstract][Full Text] [Related]
32. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous and induced tolerance for liver transplant recipients.
Feng S
Curr Opin Organ Transplant; 2016 Feb; 21(1):53-8. PubMed ID: 26709575
[TBL] [Abstract][Full Text] [Related]
34. Belatacept: from rational design to clinical application.
Wekerle T; Grinyó JM
Transpl Int; 2012 Feb; 25(2):139-50. PubMed ID: 22151353
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppression after kidney transplantation.
Kihm LP; Zeier M; Morath C
Minerva Urol Nefrol; 2011 Mar; 63(1):45-57. PubMed ID: 21336245
[TBL] [Abstract][Full Text] [Related]
36. Current and future immunosuppressive strategies in renal transplantation.
Hardinger KL; Koch MJ; Brennan DC
Pharmacotherapy; 2004 Sep; 24(9):1159-76. PubMed ID: 15460177
[TBL] [Abstract][Full Text] [Related]
37. Contemporary immunosuppression in renal transplantation.
Luke PP; Jordan ML
Urol Clin North Am; 2001 Nov; 28(4):733-50. PubMed ID: 11791490
[TBL] [Abstract][Full Text] [Related]
38. Novel immunosuppressants.
Krieger NR; Emre S
Pediatr Transplant; 2004 Dec; 8(6):594-9. PubMed ID: 15598332
[TBL] [Abstract][Full Text] [Related]
39. The search for immunosuppressive therapies to induce tolerance in organ transplantation.
Chiang KC; Ohmori N; Goto T
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):173-80. PubMed ID: 21476964
[TBL] [Abstract][Full Text] [Related]
40. Strategies for Liver Transplantation Tolerance.
Cvetkovski F; Hexham JM; Berglund E
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
